2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis

被引：0

作者：

Machado, Pedro ^{[1
]}

Bogas, Monica ^{[1
]}

Ribeiro, Ana ^{[1
]}

Costa, Jose ^{[1
]}

Neto, Adriano ^{[1
]}

Sepriano, Alexandre ^{[1
]}

Raposo, Ana ^{[1
]}

Cravo, Ana Rita ^{[1
]}

Vilar, Antonio ^{[1
]}

Furtado, Carolina ^{[1
]}

Ambrosio, Catarina ^{[1
]}

Miguel, Claudia ^{[1
]}

Vaz, Claudia ^{[1
]}

Catita, Cristina ^{[1
]}

Nour, Dolores ^{[1
]}

Araujo, Domingos ^{[1
]}

Vieira-Sousa, Elsa ^{[1
]}

Teixeira, Filipa ^{[1
]}

Brandao, Filipe ^{[1
]}

Canhao, Helena ^{[1
]}

Cordeiro, Ines ^{[1
]}

Goncalves, Ines ^{[1
]}

Ferreira, Joana ^{[1
]}

Fonseca, Joao Eurico ^{[1
]}

Pereira da Silva, Jose Alberto ^{[1
]}

Romeu, Jose ^{[1
]}

Ferreira, Julia ^{[1
]}

Costa, Lucia ^{[1
]}

Mauricio, Luis ^{[1
]}

Cunha-Miranda, Luis ^{[1
]}

Parente, Manuela ^{[1
]}

Coutinho, Margarida ^{[1
]}

Cruz, Margarida ^{[1
]}

Oliveira, Margarida ^{[1
]}

Salvador, Maria Joao ^{[1
]}

Santos, Maria Jose ^{[1
]}

Pinto, Patricia ^{[1
]}

Valente, Paula ^{[1
]}

Abreu, Pedro ^{[1
]}

Roque, Raquel ^{[1
]}

Ramiro, Sofia ^{[1
]}

Capela, Susana ^{[1
]}

Las, Vera ^{[1
]}

Barcelos, Anabela ^{[1
]}

机构：

[1] Hosp Univ Coimbra, Serv Reumatol, P-3000075 Coimbra, Portugal

来源：

ACTA REUMATOLOGICA PORTUGUESA | 2012年 / 37卷 / 01期

关键词：

Spondyloarthritis; Psoriatic arthritis; Biological therapies; Guidelines; ANTITUMOR-NECROSIS-FACTOR; ACTIVE ANKYLOSING-SPONDYLITIS; SOCIETY CLASSIFICATION CRITERIA; INFORMING RESPONSE CRITERIA; MINIMAL DISEASE-ACTIVITY; ACTIVITY SCORE ASDAS; LONG-TERM TREATMENT; DOUBLE-BLIND; AXIAL SPONDYLOARTHRITIS; RHEUMATOID-ARTHRITIS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To develop recommendations for the treatment of psoriatic arthritis (PsA) with biological therapies, endorsed by the Portuguese Society of Rheumatology. Methods: These treatment recommendations were formulated by Portuguese rheumatologists based on literature evidence and consensus opinion. A draft of the recommendations was first circulated to all Portuguese rheumatologists and their suggestions were incorporated in the draft. At a national meeting the recommendations were discussed and all attending rheumatologists voted on the level of agreement for each recommendation. A second draft was again circulated before publication. Results: A consensus was achieved regarding the initiation, assessment of response and switching biological therapies in patients with PsA. Specific recommendations were developed for several disease domains: peripheral arthritis, axial disease, enthesitis and dactylitis. Conclusion: These recommendations may be used for guidance in deciding which patients with PsA should be treated with biological therapies. They cover a rapidly evolving area of therapeutic intervention. As more evidence becomes available and more biological therapies are licensed, these recommendations will have to be updated.

引用

页码：26 / 39

页数：14

共 131 条

[1]

[Anonymous], 2006, REUMATOL CLIN, V2, P78, DOI DOI 10.1016/S1699-258X(06)73026-1

[2]

[Anonymous], NICE TECHN APPR GUID

[3] Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial [J].

Antoni, C ;

Krueger, GG ;

de Vlam, K ;

Birbara, C ;

Beutler, A ;

Guzzo, C ;

Zhou, B ;

Dooley, LT ;

Kavanaugh, A .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1150-1157

[4] Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis - Results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT) [J].

Antoni, CE ;

Kavanagh, A ;

Kirkham, B ;

Tutuncu, Z ;

Burmester, GR ;

Schneider, U ;

Furst, DE ;

Molitor, J ;

Keystone, E ;

Gladman, D ;

Manger, B ;

Wassenberg, S ;

Weier, R ;

Wallace, DJ ;

Weisman, MH ;

Kalden, JR ;

Smolen, J .

ARTHRITIS AND RHEUMATISM, 2005, 52 (04) :1227-1236

[5] Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study [J].

Arends, Suzanne ;

Brouwer, Elisabeth ;

van der Veer, Eveline ;

Groen, Henk ;

Leijsma, Martha K. ;

Houtman, Pieternella M. ;

Jansen, Tim L. Th A. ;

Kallenberg, Cees G. M. ;

Spoorenberg, Anneke .

ARTHRITIS RESEARCH & THERAPY, 2011, 13 (03)

[6]

Ash Z, 2011, ANN RHEUM D IN PRESS

[7] Clinical and Imaging Efficacy of Infliximab in HLA-B27-Positive Patients With Magnetic Resonance Imaging-Determined Early Sacroiliitis [J].

Barkham, Nick ;

Keen, Helen I. ;

Coates, Laura C. ;

O'Connor, Philip ;

Hensor, Elizabeth ;

Fraser, Alexander D. ;

Cawkwell, Lorna S. ;

Bennett, Alexander ;

McGonagle, Dennis ;

Emery, Paul .

ARTHRITIS AND RHEUMATISM, 2009, 60 (04) :946-954

[8] Persistent clinical efficacy and safety of anti-tumour necrosis factor a therapy with infliximab in patients with ankylosing spondylitis over 5 years:: evidence for different types of response [J].

Braun, J. ;

Baraliakos, X. ;

Listing, J. ;

Fritz, C. ;

Alten, R. ;

Burmester, G. ;

Krause, A. ;

Schewe, S. ;

Schneider, M. ;

Soerensen, H. ;

Zeidler, H. ;

Sieper, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) :340-345

[9] Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial [J].

Braun, J ;

Brandt, J ;

Listing, J ;

Zink, A ;

Alten, R ;

Golder, W ;

Gromica-Ihle, E ;

Kellner, H ;

Krause, A ;

Schneider, M ;

Sörensen, H ;

Zeidler, H ;

Thriene, W ;

Sieper, J .

LANCET, 2002, 359 (9313) :1187-1193

[10] The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications [J].

Bonnie Bruce ;

James F Fries .

Health and Quality of Life Outcomes, 1 (1)

← 1 2 3 4 5 6 7 8 9 10 →